William Hickling
Neurology with Special Qualifications in Child Neurology · Greensboro, NCNPI 1659337624
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 204 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,169 and has fallen 98.8% since, to $14 in 2023.
Across 204 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$891
- Supernus Pharmaceuticals, Inc.$463
- Greenwich Biosciences, Inc.$389
- Aquestive Therapeutics, Inc.$385
- Neurelis, Inc.$311
- Eisai Inc.$206
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,716100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 37 | $891 |
| Supernus Pharmaceuticals, Inc. | 37 | $463 |
| Greenwich Biosciences, Inc. | 17 | $389 |
| Aquestive Therapeutics, Inc. | 23 | $385 |
| Neurelis, Inc. | 20 | $311 |
| Eisai Inc. | 9 | $206 |
| Sunovion Pharmaceuticals Inc. | 13 | $199 |
| Philips North America LLC | 6 | $96 |
| Livanova USA, Inc. | 3 | $86 |
| Mallinckrodt Enterprises LLC | 3 | $77 |
| Upsher-smith Laboratories LLC | 4 | $76 |
| Novartis | 4 | $73 |
| Jazz Pharmaceuticals Inc. | 2 | $57 |
| Aprecia Pharmaceuticals, LLC | 3 | $55 |
| Sarepta Therapeutics, Inc. | 2 | $47 |
| Biogen | 3 | $46 |
| Tris Pharma Inc | 2 | $42 |
| Amneal Pharmaceuticals LLC | 3 | $33 |
| SK Life Science, Inc. | 2 | $29 |
| Biocodex, Inc. | 1 | $27 |
| Biomarin Pharmaceutical Inc. | 2 | $27 |
| Amgen | 1 | $24 |
| Grifols USA, LLC | 1 | $19 |
| Corium, LLC | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Zogenix Inc. | 1 | $13 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
| Travere Therapeutics, Inc. | 2 | $2 |
How this compares
$3,718 in reported general payments places this provider in the 70th percentile of 46 neurology with special qualifications in child neurology providers in North Carolina.
See all neurology with special qualifications in child neurology providers in North Carolina →
Other neurology with special qualifications in child neurology in Greensboro
- Natalie KatzDurham$60K
- Shana WallaceCharlotte$58K
- Kevin RathkeDurham$39K
- Robert NahouraiiConcord$37K
- Shalaka IndulkarFayetteville$19K
- Khaled JreisatWilmington$13K
- Traci SheafferRaleigh$9K
- Danielle WyantDurham$9K
- Virinder NohriaFranklin$7K
- Sasidharan TaravathJacksonville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.